Robert P. Gasparini
Director/Board Member at HEALTHLYNKED CORP.
Net worth: 164 171 $ as of 2024-03-30
Profile
Robert P.
Gasparini is currently the Director at CirculoGene Theranostics, Inc. since 2022 and the Independent Director at Healthlynked Corp.
since 2019.
Previously, he held positions such as President, Director & Chief Scientific Officer at NeoGenomics, Inc. from 2004 to 2014, Technical Director-Genetics at Tufts University from 1990 to 1993, Assistant Director-Cytogenetics Laboratory at Prenatal Diagnostic Center from 1993 to 1997, President, Director & Chief Scientific Officer at US Pathology Labs, Inc. from 2001 to 2014, and Manager-Worldwide & Strategic Marketing at Ventana Medical Systems, Inc. from 1998 to 2001.
He also served as an Assistant Professor at the University of Connecticut from 1985 to 1993.
Mr. Gasparini holds a graduate degree from Quinnipiac University and an undergraduate degree from the University of Connecticut.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HEALTHLYNKED CORP
1.08% | 2023-09-26 | 2,880,191 ( 1.08% ) | 164 171 $ | 2024-03-30 |
Robert P. Gasparini active positions
| Companies | Position | Start |
|---|---|---|
| HEALTHLYNKED CORP. | Director/Board Member | 2019-04-29 |
CirculoGene Theranostics, Inc.
 CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Director/Board Member | 2022-12-07 |
Former positions of Robert P. Gasparini
| Companies | Position | End |
|---|---|---|
| NEOGENOMICS, INC. | President | 2014-08-03 |
US Pathology Labs, Inc.
 US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | President | 2013-12-31 |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Sales & Marketing | 2000-12-31 |
| Prenatal Diagnostic Center | Corporate Officer/Principal | 1996-12-31 |
| Tufts University | Corporate Officer/Principal | 1992-12-31 |
Training of Robert P. Gasparini
| Quinnipiac University | Graduate Degree |
| University of Connecticut | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEOGENOMICS, INC. | Health Services |
| Private companies | 5 |
|---|---|
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
US Pathology Labs, Inc.
US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Services |
| Prenatal Diagnostic Center | |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Health Technology |
| Healthlynked Corp. |
- Stock Market
- Insiders
- Robert P. Gasparini
